Published in Cancer Weekly, December 2nd, 2003
According to a study from the United States, "Actinic keratoses (AKs) are intra-epidermal foci of malignancy and represent the earliest clinical stage in the continuum of squamous cell carcinoma (SCC). A variety of topical, physical, and surgical modalities are available for treatment."
"Until recently, topical 5-fluorouracil was the only topical a gent approved by the U.S. Food and Drug Administration (FDA) for the treatment of AK," reported James Q. Del Rosso at the Las Vegas Skin and Cancer Clinic. "Topical diclofenac 3%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.